Content of CYTOCON DB:
-
- Cancer stage (I-IV)
- Cancer stage for mixed groups
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- T stage of cancer (TNM)
- Severity score for acute allergic reactions
- Acute coronary syndrome
- Acute coronary syndrome, nonocclusive type (unstable angina)
- Acute coronary syndrome, occlusive type (transmural myocardial infarction)
- Acute disseminated encephalomyelitis (ADEM)
- Anti-HBe seropositivity
- Child–Pugh stage
- Disease duration
- HBcAb seropositivity
- HBeAg seropositivity
- HBsAb seropositivity
- HBsAg seropositivity
- Period of infection disease
- Acute lymphoblastic leukemia
- Acute lymphoid leukaemia
- ECOG status
- FAB classification subtype
- % of deaths
- APACHE II score
- Balthazar score
- BISAP score
- Glasgow severity score
- MCTSI score
- Ranson score
- Severity
- SOFA, Sepsis-related organ failure assessment score
- Acute pyelonephritis
- Anti-HBe seropositivity
- Clinical outcome
- HBeAg seropositivity
- HBsAb seropositivity
- MELD score
- Cancer stage (I-IV)
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- T stage of cancer (TNM)
- Adenocarcinoma of cervix
- Cancer stage (I-IV)
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- T stage of cancer (TNM)
- Tumor differentiation
- Adenocarcinoma of stomach
- Cancer stage (I-IV)
- Cancer stage for mixed groups
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- T stage of cancer (TNM)
- Adenosquamous carcinoma of bronchus or lung
- Adult T-cell leukaemia/lymphoma (ATLL)
- adult-onset Still’s disease (AOSD)
- AIDS
- AIDS-related non-Hodgkin lymphoma
- Mini Mental State Examination (MMSE)
- PD20 methacholine
- Wheal diameter induced by allergen (mm)
- Allergic contact dermatitis
- FEV1, % predicted
- PD20 methacholine
- Wheal diameter induced by allergen (mm)
- Alveolar rhabdomyosarcoma
- Alveolar soft part sarcoma
- APOE4 status
- Clinical dementia rating (CDR)
- Disease duration
- Mini Mental State Examination (MMSE)
- Aneurysmal diameter
- Modified Fisher score (MFS)
- Severity
- WFNS grade (World Federation of Neurological Surgeons)
- Angiosarcoma
- ASDAS
- BASDAI
- BASFI
- BASMI
- Disease duration
- HLA-B27 seropositivity
- Disease duration
- ECOG status
- Severity
- Appendicitis and Diverticulitis
- % reversibility
- Aas score
- Airway resistance
- Asthma control test (ACT) score
- Asthma status
- Atopy
- Daily dose of ICS
- Disease duration
- FeNO
- FEV1 (L/min)
- FEV1 after salbutamol (% predicted)
- FEV1 before salbutamol (% predicted)
- FEV1, % predicted
- FEV1, L
- FEV1/FVC
- FVC (% predicted)
- FVC, L
- Global Initiative for Asthma (GINA)
- IgE total
- Patient # on ICS
- PC20 аfer methacholine
- PEF (peak expiratory flow)
- Phase
- Severity
- TLC (% predicted)
- Asthma, food allergy and atopic dermatitis
- FEV1, % predicted
- FEV1, L
- Phase
- Anti-HBe seropositivity
- HBcAb seropositivity
- HBsAb seropositivity
- Atopic allergy
- Atopic asthma
- AD phase
- AD type
- CDLQI - Children’s Dermatology Life Quality Index
- Disease duration
- EASI
- Extent (%) - affected Body Surface Area (BSA))
- IGA
- IgE specific
- IgE total
- oSCORAD
- Pruritus (VAS)
- Pruritus score
- SCORAD
- Severity
- SH (Skin Hydration)
- Sleep loss
- TEWL
- VAS
- FEV1, % predicted
- FEV1, L
- PC20 аfer methacholine
- Atrial fibrillation
- Atypical autism (F84.1)
- Atypical hyperplasia
- Autism (F84.0)
- Autism spectrum disorder
- EDSS score
- Modified Rankin Scale
- Activity of inflammation
- Fibrosis stage
- IAIHG criteria score
- Autoimmune pancreatitis
- B chronic lymphocytic leukemia
- Bacterial sepsis-ARDS
- Basal cell carcinoma
- Minimal residual disease (MRD)
- B-cell non-Hodgkin lymphoma (B-NHL)
- B-cell precursor acute lymphoblastic leukemia (BCP-ALL)
- Disease duration
- Stage
- The Behcet’s Disease Current Activity Form (BDCAF) transformed index
- Benign conditions of ovary and uterus
- Benign lung lesions
- Benign ovarian pathologies
- Benign prostatic hyperplasia
- Benign reactive lymphoid hyperplasia
- Benign soft-tissue neoplasm
- Cancer stage (I-IV)
- Clinical outcome
- ECOG status
- Histological grade
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- Severity
- T stage of cancer (TNM)
- Brain trauma
- Breast benign tumor
- % of deaths
- Cancer stage (I-IV)
- Clinical outcome
- Disease duration
- ECOG status
- ER status
- Her2 expression
- Histological grade
- Histology type
- Lymph node metastasis
- Lymphovascular space invasion (LVSI)
- M stage of cancer (TNM)
- Molecular subtype
- N stage of cancer (TNM)
- PR expression
- Severity
- T stage of cancer (TNM)
- TIL PD-L1 expression
- Tumor cell PD-L1 expression
- Tumor size (cm)
- Tumor type
- WHO grade
- Breast carcinoma
- Breast ductal carcinoma
- Bronchial asthma
- FEV1 after salbutamol (% predicted)
- Bronchioalveolar adenocarcinoma
- Bronchoalveolar carcinoma
- BP180-NC16A
- BP230-CF
- BPDAI Blisters/erosions score
- BPDAI Erythema/urticaria score
- BPDAI score
- BPDAI skin activity score
- Disease duration
- Number of lesions
- Pruritus score
- Severity
- Stage
- Burns
- Carcinoma
- CD40L deficiency
- Celiac disease
- Central nervous system infection
- Mini Mental State Examination (MMSE)
- Cancer stage (I-IV)
- Clinical outcome
- ECOG status
- FIGO stage of UCC
- Histological grade
- Histology type
- HPV-positivity
- Lymph node metastasis
- Lymphovascular space invasion (LVSI)
- Severity
- Tumor size
- Cervical carcinoma
- Cancer stage (I-IV)
- HPV-positivity
- Chest infections
- Chondrosarcoma
- Chordoma
- Chronic atrophic gastritis
- Chronic Bronchial Asthma
- FEV1 after salbutamol (% predicted)
- FEV1 before salbutamol (% predicted)
- Chronic calculous cholecystitis
- Chronic hepatitis
- Activity of inflammation
- Anti-HBe seropositivity
- Clinical outcome
- Disease duration
- Fibrosis score
- Fibrosis stage
- HBcAb seropositivity
- HBcAg Expression Patterns in Hepatocyte
- HBeAg seropositivity
- HBsAb seropositivity
- HBsAg Expression Patterns in Hepatocyte
- HBsAg seropositivity
- HBV genotype
- Histological activity index
- Inflammation grade
- Ishak grading total
- Ishak staging
- Knodell histologic activity index
- MELD score
- parenchymal liver disease (PLD) score
- Period of infection disease
- Phase
- Severity
- APRI
- Disease duration
- FIB-4
- Fibrosis score
- Fibrosis stage
- HCV genotype
- HCV serology
- IgM-Rheumatoid factor seropositivity
- Inflammation grade
- Ishak staging
- Period of infection disease
- Chronic idiopathic urticaria, hives
- Chronic kidney disease
- Clinical form
- Disease duration
- Chronic myelogenous leukemia
- Chronic myeloid leukaemia
- Atopy
- BODE Index
- CMI (Charlson Comorbidity Index)
- Disease duration
- FEV1, % predicted
- FEV1, L
- FEV1/FVC
- FVC (% predicted)
- FVC, L
- GOLD
- GOLD classification
- Phase
- Severity
- Chronic pancreatitis
- Chronic Spontaneous Urticaria
- Chronic superficial gastritis
- Clear cell sarcoma
- Clinically isolated syndrome
- Endomysium antibodies seropositivity
- IgA class R1-type reticulin seropositivity
- Marsh score
- Colitis associated cancer (CAC)
- Collagenous colitis
- Colon adenocarcinoma
- Colon carcinoma
- Colonic cancer
- Cancer stage (I-IV)
- Clinical outcome
- Disease duration
- ECOG status
- Histological grade
- Histological score
- Liver metastases
- Localization of the disease
- Lymph node metastasis
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- Severity
- T stage of cancer (TNM)
- Tumor differentiation
- Tumor size (cm)
- WHO grade
- Colorectal carcinoma
- Colorectal polyp
- Community acquired pneumonia
- Contact dermatitis
- % of deaths
- APACHE II score
- ARDS-Berlin score severity
- Cancer stage (I-IV)
- Clinical outcome
- CT score
- DASO (Days after symptom onset)
- Disease duration
- ECOG status
- Histological grade
- HScore
- NEWS (National Early Warning Score)
- NIH Ordinal Scale
- PSI, pneumonia severity index
- SAPS, simplified acute physiology score
- SARS-COV2 confirmed by PCR (%)
- Severity
- SOFA, Sepsis-related organ failure assessment score
- WHO score
- COVID-19 pneumonia
- Clinical activity index (HBI)
- Clinical form
- Crohn’s Disease Activity Index (CDAI)
- Crohn’s Disease Endoscopic Index of Severity (CDEIS)
- Disease activity
- Disease duration
- Endoscopic activity score (Rutgeerts)
- Harvey-Bradshaw Index (HBI) Score
- Histological score
- Index of inflammatory bowel disease (IOIBD)
- Localization of the disease
- Montreal age
- Montreal Behavior
- Montreal Location
- PCDAI (pediatric Crohn's disease activity index)
- Phase
- SES-CD
- Severity
- Simple Endoscopy Severity (SES)
- Stage
- Cutaneous Lupus Erythematosus
- Cutaneous squamous cell carcinoma
- Cyclic neutropenia
- FEV1, % predicted
- FVC (% predicted)
- TLC (% predicted)
- Dedifferentiated liposarcoma
- Deep vein thrombosis
- Disease duration
- Mini Mental State Examination (MMSE)
- Dengue
- 16-HDRS
- Beck Depression Inventory (BDI)
- BPQ
- Mini Mental State Examination (MMSE)
- Dermatitis herpetiformis
- Dermatophytosis
- Desmoplastic small round cell tumour
- DFSP dermatofibrosarcoma protuberans
- Diffuse large B-cell lymphoma
- Discoid Lupus Erythematosus
- Dysbacteriosis
- Dysmyelopoiesis
- Early arthritis
- Embryonal rhabdomyosarcoma
- End stage renal disease
- Endometrial carcinoma
- Phase of the menstrual cycle
- rASRM stage
- End-stage kidney disease
- End-stage renal failure
- Eosinophilia
- Atopy
- FEV1 after salbutamol (% predicted)
- FEV1, % predicted
- PC20 аfer methacholine
- Epithelioid sarcoma
- Epstein-Barr virus (EBV) infection
- Erythema multiforme
- Cancer stage (I-IV)
- Clinical outcome
- ECOG status
- Histological grade
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- Severity
- T stage of cancer (TNM)
- TEWL
- Cancer stage (I-IV)
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- T stage of cancer (TNM)
- Ewing sarcoma
- Familial lecithin:cholesterol acyltransferase (LCAT) deficiency
- Familial lipoprotein lipase (LPL) deficiency
- Fanconi anaemia
- Fibrotic hypersensitivity pneumonitis
- Focal segmental glomerulosclerosis
- Follicular lymphoma
- Food allergy and atopic dermatitis
- Mini Mental State Examination (MMSE)
- Gallbladder cancer
- Gallbladder dysplasia
- Gastric adenocarcinoma
- % of deaths
- Bormann type
- Cancer stage (I-IV)
- Clinical outcome
- ECOG status
- H. pylori antibody
- Her2 expression
- Histological grade
- Histology type
- Localization of the disease
- Lymph node metastasis
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- Severity
- T stage of cancer (TNM)
- Tumor size
- Tumor size (cm)
- Gastric ulcer
- Cancer stage (I-IV)
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- T stage of cancer (TNM)
- Gliosarcoma
- Gout
- Disease duration
- Goiter degree
- GREAT score
- GREAT score classes
- Ophthalmopathy
- Disease duration
- HOMA score (Homeostatic model assessment)
- Ophthalmopathy
- Fibrosis stage
- HBeAg seropositivity
- HBsAg seropositivity
- Inflammation grade
- Child–Pugh stage
- HBeAg seropositivity
- Phase
- N stage of cancer (TNM)
- T stage of cancer (TNM)
- Tumor differentiation
- % of deaths
- Cancer stage (I-IV)
- Disease duration
- Histological grade
- HPV-positivity
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- T stage of cancer (TNM)
- Tumor differentiation
- Tumor site
- Antinuclear antibody (ANA)-positivity
- APACHE II score
- APOE4 status
- ASA
- Atopy
- BODE Index
- BPQ
- Clinical dementia rating (CDR)
- CMI (Charlson Comorbidity Index)
- ELF score (enhanced liver fibrosis)
- Endomysium antibodies seropositivity
- FEV1 after salbutamol (% predicted)
- FEV1 before salbutamol (% predicted)
- FEV1, % predicted
- FEV1, L
- FEV1/FVC
- FVC (% predicted)
- FVC, L
- HBsAg seropositivity
- HCV serology
- HOMA score (Homeostatic model assessment)
- HPV-positivity
- IgA class R1-type reticulin seropositivity
- IgG index
- Metabolic syndrome (IDF criteria)
- Mini Mental State Examination (MMSE)
- PC20 аfer methacholine
- Performance status (ECOG/WHO)
- Phase of the menstrual cycle
- Child–Pugh stage
- HBeAg seropositivity
- Knodell histologic activity index
- Phase
- Hepatitis non-infectious
- BCLC stage
- Cancer stage (I-IV)
- Cancer stage for mixed groups
- Child–Pugh stage
- Clinical outcome
- CLIP score
- Distant metastasis
- ECOG status
- HAI score
- HBeAg seropositivity
- HBsAg seropositivity
- HCV serology
- HCV-Ab seropositivity
- Histological grade
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- Number of tumors
- Okuda staging system
- Severity
- T stage of cancer (TNM)
- Tumor size (cm)
- Up-to-7 criteria
- Vasoinvasion
- APRI
- Disease duration
- FIB-4
- Fibrosis stage
- HBeAg seropositivity
- HBsAg seropositivity
- HIV-infection stage
- Ishak staging
- Ann Arbor stage
- B symptoms present
- Histology
- Histology type
- Serum lactate dehydrogenase level
- Serum level of beta2-microglobulin
- Human immunodeficiency virus (HIV-1) infection
- Human immunodeficiency virus (HIV-2) infection
- Hypopharyngeal squamous cell carcinoma
- Idiopathic aplastic anemia
- Idiopathic inflammatory myopathies
- Idiopathic membranous nephropathy
- Idiopathic pulmonary fibrosis
- IgA-deficiency disorder
- Antinuclear antibody (ANA)-positivity
- Clinical form
- Disease duration
- ELF score (enhanced liver fibrosis)
- IgG4-RD RI (Responder Index)
- Number of organs involved
- Physician Global Assessment (PGA)
- Rheumatoid factor (RF) seropositivity
- Immune aplastic anemia
- Anti-Glycoprotein (anti-GP) autoantibody
- Bleeding grade
- Buchanan score
- Clinical form
- Disease duration
- Severity
- Immune thrombocytopenic purpura
- Immunoglobulin (Ig)G subclass-deficiency
- % of deaths
- CMI (Charlson Comorbidity Index)
- qSOFA (quick Sequential Organ Failure Assessment)
- SOFA, Sepsis-related organ failure assessment score
- Infectious colitis
- Clinical activity index (HBI)
- Clinical activity index (Mayo)
- Disease duration
- Endoscopic activity score (Mayo)
- Endoscopic activity score (Rutgeerts)
- Endoscopic severity (Mayo)
- Harvey-Bradshaw Index (HBI) Score
- Simple Endoscopy Severity (SES)
- Stage
- Inflammatory breast cancer (IBC)
- Inflammatory skin diseases
- % of deaths
- % reversibility
- Severity
- SOFA, Sepsis-related organ failure assessment score
- % of deaths
- APACHE II score
- SOFA, Sepsis-related organ failure assessment score
- DLCOc (% predicted)
- FEV1, % predicted
- FVC (% predicted)
- TLC (% predicted)
- Interstitial pneumonia with autoimmune features
- Irritable Bowel Syndrome
- Ischemic stroke
- Juvenile chronic arthritis
- Antinuclear antibody (ANA)-positivity
- Disease activity
- Extent of joints involvement
- Rheumatoid factor (RF) seropositivity
- Kawasaki disease
- Langerhans cell histiocytosis
- Large cell carcinoma of bronchus or lung
- Laryngeal papilloma
- Laryngeal Squamous Cell Carcinoma
- Leiomyosarcoma
- Cancer stage (I-IV)
- Clinical outcome
- ECOG status
- Histological grade
- Severity
- Child–Pugh stage
- HBeAg seropositivity
- HBsAg seropositivity
- Liver hemangioma
- Low-grade fibromyxoid sarcoma
- Cancer stage (I-IV)
- Clinical outcome
- ECOG status
- FEV1, % predicted
- Histological grade
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- Performance status (ECOG/WHO)
- Severity
- T stage of cancer (TNM)
- Lung squamous cell carcinoma
- AI (activity index)
- ANA titer
- Anti-dsDNA
- Anti-ds-DNA positivity
- Antinuclear antibody (ANA)-positivity
- Chronicity index (CI)
- Disease duration
- Glomerulonephritis class
- ISN/RPS (International Society of Nephrology/Renal Pathology Society) class
- Positivity of anti-Sm
- Positivity of anti-SSA/SSB
- SLEDAI
- SLEDAI 2K
- Stage
- Lymphadenopathic mastocytosis with eosinophilia
- Lymphocytic colitis
- Macrophage activation syndrome
- Major depressive disorder
- Malignant melanoma
- Cancer stage (I-IV)
- Cancer stage for mixed groups
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- T stage of cancer (TNM)
- Ann Arbor stage
- B symptoms present
- ECOG status
- Mastocytosis
- % of deaths
- Breslow score
- Cancer stage (I-IV)
- Cancer stage for mixed groups
- Clark's level
- Distant metastasis
- Lymph node metastasis
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- T stage of cancer (TNM)
- Metaplastic breast carcinoma
- Microcrystal arthritis
- Mini Mental State Examination (MMSE)
- Mini Mental State Examination (MMSE)
- Mini Mental State Examination (MMSE)
- Minimal change disease (MCD, minimal change glomerulopathy)
- Mixed germ cell tumor
- Mixed granulocytic asthma
- Monoclonal gammopathy of undetermined significance (MGUS)
- Morbidly obese
- MPNST malignant peripheral nerve sheath tumor
- Cancer stage (I-IV)
- Cancer stage for mixed groups
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- T stage of cancer (TNM)
- Bone Lesion Score
- Cancer stage (I-IV)
- Disease duration
- Durie-Salmon stage
- ISS stage
- WHO grade
- Beck Depression Inventory (BDI)
- Blood-Brain Barrier impairment
- CIS20r Concentration
- CIS20r Fatigue
- CIS20r Motivation
- CIS20r Physical activity
- Clinical form
- Disease duration
- EDSS score
- IgG index
- MSIS-29 physical
- MSIS-29 psychological
- MSSS (multiple sclerosis severity score)
- Number of relapses (attacks)
- Oligoclonal bands (OCB)
- SDMT
- Severity
- Multisystem inflammatory syndrome associated with COVID-19
- Myasthenia gravis
- Mycosis fungoides
- % of deaths
- IPSS-R (Revised International Prognostic Scoring System)
- Myelomonocytic leukemia
- Myoma
- Myxofibrosarcoma
- Myxoid/round cell liposarcoma (MRCL)
- Cancer stage (I-IV)
- Clinical outcome
- ECOG status
- Histological grade
- Severity
- Nasopharyngeal squamous cell carcinoma
- Neuroblastoma
- Blood-Brain Barrier impairment
- Disease duration
- anti-AQP4 antibody seropositivity
- Clinical form
- EDSS score
- IgG index
- Neuromyelitis optica spectrum disorder
- Atopy
- FEV1 after salbutamol (% predicted)
- Nocturnal Asthma
- Non-atopic asthma
- Nonautoimmune diseases
- Non-eosinophilic asthma
- Non-Hodgkin Lymphoma
- Non-Hodgkin's lymphoma and Hodgkin's lymhoma patients
- Non-idiopathic pulmonary fibrosis
- Non-infected ICU patients
- % of deaths
- APACHE IV score
- CMI (Charlson Comorbidity Index)
- qSOFA (quick Sequential Organ Failure Assessment)
- SOFA, Sepsis-related organ failure assessment score
- % of deaths
- Cancer stage (I-IV)
- Cancer stage for mixed groups
- Distant metastasis
- EGFR mutation
- FEV1, % predicted
- FEV1, L
- Histology type
- KRAS mutation
- Lymph node metastasis
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- Performance status (ECOG/WHO)
- T stage of cancer (TNM)
- Non-squamous bronchial carcinoma
- Nontoxic multinodular goitre
- Non-translocation sarcoma
- Novel coronavirus pneumonia
- Nummular Eczema
- Obesity
- Oesophageal squamous cell cancer
- Oral cavity squamous cell carcinoma
- Oral leukoplakia
- Oral squamous cell carcinoma
- Oral submucous fibrosis
- Oropharyngeal squamous cell carcinoma
- Anti-CCP antibody [ACPA] positivity
- Disease duration
- KL grade
- Rheumatoid factor (RF) seropositivity
- Osteoarthritis inflammatory
- Osteosarcoma
- Other inflammatory neurological disorders
- Ovarian clear cell carcinoma
- Pancreatic adenocarcinoma
- aSMA H-score
- Cancer stage (I-IV)
- Cancer stage for mixed groups
- Collagen H-Score
- ECOG status
- Histological grade
- Histology type
- T stage of cancer (TNM)
- WHO grade
- Pancreatic ductal adenocarcinoma
- Parenchymal neuro-Behçet's syndrome
- Parotid gland acinic cell carcinoma
- Parotid gland myoepithelioma
- Parotid gland pleomorphic adenoma
- Parotid gland Warthin’s tumor
- Atopy
- FEV1 after salbutamol (% predicted)
- Pleomorphic adenoma
- HOMA score (Homeostatic model assessment)
- Polycythaemia vera
- Primary angle closure glaucoma
- Primary biliary cholangitis
- Primary bronchial carcinoma
- Primary immune thrombocytopenia
- Primary progressive multiple sclerosis
- Disease duration
- ESSDAI
- ESSPRI
- Primitive neuroectodermal tumor
- Progressive supranuclear palsy (PSP)
- Cancer stage (I-IV)
- Clinical outcome
- D'Amico risk group
- ECOG status
- Histological grade
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- Severity
- T stage of cancer (TNM)
- Clinical form
- Disease duration
- DLQI
- IgE specific
- IgE total
- Metabolic syndrome (IDF criteria)
- NAPSI
- PASI
- Severity
- SPARCC
- Swollen joint count
- Anti-CCP antibody [ACPA] positivity
- BASDAI
- Clinical disease activity index (CDAI)
- DAPSA
- DAS28
- DAS28-ESR
- Disease duration
- Joint count
- MASES
- PASI
- Physician Global Assessment (PGA)
- Radiological score of sacroileitis
- Rheumatoid factor (RF) seropositivity
- SDAI
- SPARCC
- Swollen joint count
- Swollen joint count (28-joint score)
- Tender joint count (28-joint score)
- VAS-PAIN
- Disease duration
- HLA-B27 seropositivity
- Recurrent depressive disorders
- Refractory Bone and Soft Tissue Sarcoma
- Relapsing-remitting multiple sclerosis
- Cancer stage (I-IV)
- Clinical outcome
- ECOG status
- Histological grade
- Histology type
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- Severity
- T stage of cancer (TNM)
- WHO grade
- Renal cell carcinoma
- Renal dysfunction
- Respiratory syncytial virus (RSV) pneumonia
- Anti-CCP antibody [ACPA] positivity
- Clinical disease activity index (CDAI)
- DAS28
- DAS28CRP
- DAS28-ESR
- DAS44 score
- Disease activity
- Disease duration
- DLCOc (% predicted)
- FEV1, % predicted
- FVC (% predicted)
- HAQ-DI
- IgM-Rheumatoid factor seropositivity
- Larsen grade
- Larsen score
- Rheumatoid factor (RF) seropositivity
- SDAI
- Stage
- Swollen joint count (28-joint score)
- Swollen joint count (66-joint score)
- Tender joint count (28-joint score)
- Tender joint count (68-joint score)
- TLC (% predicted)
- Cancer stage for mixed groups
- FEV1, % predicted
- FVC (% predicted)
- Sarcoidosis stages (chest radiograph stages (Scadding criteria))
- Stage
- SARS-CoV-2 pneumonia
- Clinical form
- Disease duration
- FEV1, % predicted
- MRSS
- Sclerosing lymphocytic lobulitis of the breast
- Seborrheic keratosis
- Secondary progressive multiple sclerosis
- % of deaths
- APACHE IV score
- ASA
- CMI (Charlson Comorbidity Index)
- MEDS score
- qSOFA (quick Sequential Organ Failure Assessment)
- Severity
- SOFA, Sepsis-related organ failure assessment score
- Sezary syndrome
- Cancer stage (I-IV)
- Histology type
- Localization of the disease
- Lymph node metastasis
- T stage of cancer (TNM)
- Tumor size (cm)
- Small bowel Crohn's disease
- Cancer stage for mixed groups
- Marburg stage
- Cancer stage (I-IV)
- ECOG status
- Soft tissue sarcoma
- Solid malignant tumors
- Solitary fibrous tumor
- Anti-CCP antibody [ACPA] positivity
- ASDAS
- BASDAI
- Rheumatoid factor (RF) seropositivity
- Spondyloarthropathy
- Sporadic colorectal cancer (SCRC)
- Cancer stage (I-IV)
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- T stage of cancer (TNM)
- Cancer stage (I-IV)
- Disease duration
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- T stage of cancer (TNM)
- Squamous cell lung cancer
- Stable angina
- Stable coronary artery disease (SCAD)
- Stat3-Hyper-IgE syndrome
- Stomach cancer
- Symptomatic cartilage defects
- Synovial sarcoma
- System indolent mastocytosis
- AECA (anti-endothelial cell antibodies)
- ANA titer
- Anti-dsDNA
- Anti-ds-DNA positivity
- Anti-dsDNA/reference anti-dsDNA
- Anti-La titre
- Antinuclear antibody (ANA)-positivity
- Anti-Ro titre
- Disease duration
- GS dose
- GS dose 2
- IFNGS type
- Mex-SLEDAI
- Phase
- Physician Global Assessment (PGA)
- Positivity of anti-Sm
- Positivity of anti-SSA/SSB
- Rheumatoid factor (RF) seropositivity
- SDI (SLE Damage Index)
- SELENA-SLEDAI
- Severity
- SLAM (Systemic Lupus Activity Measure)
- SLE disease activity score [ECLAM]
- SLEDAI
- SLEDAI 2K
- SLICC score
- Stage
- Systemic onset juvenile idiopathic arthritis
- T-cell acute lymphoid leukemia
- T-cell non-Hodgkin lymphoma
- Thrombocytopenia
- Thrombocytosis
- Thrombosis
- Thyroid adenoma
- Cancer stage (I-IV)
- Cancer stage for mixed groups
- Clinical outcome
- ECOG status
- Histological grade
- M stage of cancer (TNM)
- N stage of cancer (TNM)
- Severity
- T stage of cancer (TNM)
- Thyroid carcinoma
- Tongue squamous cell carcinoma
- Translocation-associated sarcoma
- Traumatic ulcers
- FEV1, % predicted
- FEV1, L
- Localization of the disease
- IgG4-RD RI (Responder Index)
- Disease duration
- HbA1c level
- Type 2 autoimmune pancreatitis
- Disease duration
- HbA1c level
- Baron score (endoscopic)
- Clinical activity index (CAI)
- Clinical activity index (Mayo)
- Disease activity
- Disease duration
- Disease extent
- Endoscopic activity score (Mayo)
- Endoscopic activity score (Rutgeerts)
- Localization of the disease
- Phase
- PUCAI (pediatric ulcerative colitis activity index)
- Severity
- Stage
- Disease duration
- Rheumatoid factor (RF) seropositivity
- Unexplained recurrent anaphylaxis
- Upper gastrointestinal cancers
- UPS undifferentiated pleomorphic sarcoma
- Urinary tract infection
- Urticaria pigmentosa
- FIGO stage of UCC
- Lymph node metastasis
- Tumor differentiation
- Tumor size
- Vasoinvasion
- Uveal melanoma
- Disease duration
- Mini Mental State Examination (MMSE)
- Viral meningoencephalitis
- Well-differentiated liposarcoma
- X-linked agammaglobulinaemia
- X-linked severe combined immunodeficiency (SCID-X1)
-
-
- 12-hydroxyeicosatetraenoic acid (12-HETE)
- 13,14-dihydro-15-keto Prostaglandin E1 (PGE1)
- 13,14-dihydro-15-keto Prostaglandin E2 (PGE2)
- 15-hydroxyeicosatetraenoic acid (15-HETE)
- 25-hydroxyvitamin D (25(OH)D)
- 5-hydroxyeicosatetraenoic acid (5-HETE)
- 6-Keto-Prostaglandin F1α (6-Keto-PGF1α)
- 8-Hydroxy-2'-deoxyguanosine (8-OHdG)
- 8-isoprostane
- 9a,11b-Prostaglandin F2 (9a,11b-PGF2)
- Abeta42
- Acetylcholine
- Adenosine deaminase (ADA)
- Adiponectin
- Adipsin
- Adrenocorticotropic hormone (ACTH)
- ALA (alpha-linolenic acid)
- Alanine aminotransferase (ALT)
- Albumin
- ALP (Alkaline phosphatase)
- Alpha-1 antitrypsin
- Alpha-1 globulin
- Alpha1-fetoprotein
- Alpha-2 globulin
- Alpha2-antiplasmin (A2PI)
- Alpha2-macroglobulin (a2M)
- Alpha-tocopherol
- aMCV
- Amylase
- Androstenedione
- Angiopoietin-2
- Angiostatin
- anti-BP-180
- anti-BP-230
- anti-EGFR IgG
- anti-HBc
- Anti-HER2 IgA
- Anti-HER2 IgG
- Anti-SEA IgE (anti-staphylococcus enterotoxin A)
- Anti-SEB IgE (anti-staphylococcus enterotoxin B)
- ApoA-I
- ApoA-II
- ApoA-IV
- ApoB
- ApoC-II [Apolipoprotein C-II]
- ApoC-III
- ApoE
- APRIL
- Arachidonic Acid
- Arginase I
- Ascorbic acid
- Aspartate aminotransferase (AST)
- Axl (tyrosine-protein kinase 7)
- BAFF
- BAMBI
- Bcl-2
- Beta-2-microglobulin
- Betacellulin (BTC)
- Beta-globulin
- b-FGF (basic fibroblast growth factor, FGF2)
- Bilirubin direct
- Bilirubin indirect
- Bilirubin total
- Blood urea nitrogen
- Brain natriuretic peptide (BNP)
- Brain-derived neurotrophic factor (BDNF)
- C1q (Complement component 1q)
- C1s (Complement component 1s)
- C1s inactivator
- C2 (Complement component 2)
- C3 (Complement component 3)
- C3 PA (properdin factor B)
- C3c (Complement component 3c)
- C3d (Complement component 3d)
- C4 (Complement component 4)
- C5a receptor (CD88)
- C9 (Complement component 9)
- CA 72-4 (cancer antigen 72-4)
- CA125 (cancer antigen 125)
- CA12-5 (cancer antigen 12-5)
- CA15-3 (cancer antigen 15-3)
- CA19-9 (cancer antigen 19-9)
- Carbamide
- Carcinoembryonic antigen (CEA)
- Cardiac Troponin I (cTnI)
- Carotenoid
- Cathelicidin (LL-37)
- cccDNA
- CCL1 [C-C motif chemokine Ligand 1]
- CCL11
- CCL13
- CCL14a [C-C motif chemokine Ligand 14 alpha]
- CCL15
- CCL16 (HCC-4)
- CCL17
- CCL18
- CCL19
- CCL2
- CCL20
- CCL21
- CCL22
- CCL23
- CCL24
- CCL25
- CCL26
- CCL27
- CCL28
- CCL3
- CCL4
- CCL5 [C-C motif chemokine Ligand 5]
- CCL7
- CCL8
- CCP (Cyclic Citrullinated Peptide) antibodies
- CD200 (OX-2) glycoprotein
- CGRP [Calcitonin Gene Related Protein]
- CH50 (Hemolytic Complement 50)
- Chitinase-3-like protein 1 (YKL-40)
- Cholesterol
- Cholesteryl ester
- Cholinesterase (butyrylcholinesterase)
- ciliary neurotrophic factor (CNTF)
- CITP (carboxy-terminal telopeptide of collagen type I)
- Citrate
- CKMB (creatine kinase isoenzyme)
- clec9A
- Collagen IV (C-IV)
- Complement factor B
- Cortisol
- C-peptide
- C-reactive protein (CRP)
- Creatine kinase
- Creatinine
- CTRP15 (Complement C1q/tumor necrosis factor-related protein 15)
- CTRP6 (C1q/tumor necrosis factor- α-related protein-6)
- CX3CL1
- CXCL1
- CXCL10
- CXCL11
- CXCL12 [C-X-C motif chemokine Ligand 12]
- CXCL12a [C-X-C motif chemokine Ligand 12 alpha]
- CXCL13
- CXCL16
- CXCL2
- CXCL3
- CXCL4
- CXCL5
- CXCL6
- CXCL7
- CXCL9
- CYFRA 21.1
- Cystatin C (CysC)
- Cysteinyl leukotrienes (Cys-LTs)
- Cytokeratin18 (CK18)
- D-dimer (fibrin degradation product)
- DGLA (dihomo-gamma linolenic acid)
- DHA (Docosahexaenoic acid)
- DHEA (dehydroxyepiandrostenedione)
- DPA (Docosapentaenoic acid)
- ECP [Eosinophil Cationic Protein]
- Elafin
- Elastin-derived peptide
- EMMPRIN (CD147)
- Endoglin (CD105)
- Endotoxin
- Eosinophil protein Х (EPX)
- EPA (Eicosapentaenoic acid)
- Epidermal Growth Factor (EGF)
- ErbB2(CD340, HER-2)
- Estradiol (E2)
- FABP-2
- FABP4
- Fas
- Ferritin
- FGF
- FGF-2 ( fibroblast growth factor 2)
- FGF21
- FGL-1 (Fibrinogen-like protein 1)
- Fibrin
- Fibrin Degradation Products (FDP)
- Fibrinogen
- FLCs kappa
- FLCs lambda
- Flt3‑L
- Folate
- Folate receptor beta (FR‐beta)
- Follicle-stimulating hormone (FSH)
- Follistatin
- Free Choline
- Free Fatty acids (FFA)
- Free Glycerol
- Free testosterone
- FT3 (free triiodothyronine)
- FT4 (free thyroxine)
- Galectin-9
- Gamma-globulin
- gamma-Glutamyl Transpeptidase (GGT)
- Gamma-tocopherol
- GCSF [Granulocyte Colony-Stimulating Factor]
- GDF15
- GH (growth hormone/somatotropin)
- GHR (Growth hormone receptor)
- Glial cell-derived neurotrophic factor (GDNF)
- Globulin
- Glucose
- Glutathione peroxidase (GSH-PX)
- Glycoprotein 130 (gp130)
- Glycyl-proline-dipeptidyl aminopeptidase (GPDA)
- GMCSF [Granulocyte-Macrophage Colony-Stimulating Factor]
- Granulysin (GNLY)
- GranzymeA
- GranzymeB
- GRO [Growth-Related Oncogene]
- GSH (reduced glutathione)
- GSSG (oxidised glutathione)
- H2O2
- Haptoglobin
- HAVCR1
- hBD-2 (human β-defensin 2)
- hBD-3 (human β-defensin 3)
- HBeAg
- HB-EGF (Heparin-binding EGF-like growth factor)
- HBsAg
- HBV DNA
- HBV RNA
- HCV RNA
- HDL-cholesterol
- HDL-unesterified cholesterol
- HE4 (Human epididymis protein 4)
- HELIX-II (type II collagen helical peptide)
- Hemoglobin
- Hepatocyte growth factor (HGF)
- Hepcidin
- High mobility group box 1 (HMGB1, amphoterin)
- high sensitive troponin I (hsTnI)
- High-sensitivity C-reactive protein (hs-CRP)
- Hippurate
- Histamine
- HIV p24 antigen
- HIV RNA
- HNPs (human neutrophil peptides, defensins)
- Homocysteine
- HSP-70 (Heat shock protein‑70)
- Hyaluronic acid (HA)
- ICAM
- ICAM-1
- IFN lambda2 (IL28a)
- IFNa [Interferon alpha]
- IFNa2
- IFNb
- IFNg [Interferon gamma]
- IFNGR1
- IFN-lambda2/3
- IgA
- IgE
- IGF-1 (insulin growth factor 1)
- IGFBP-1
- IGFBP-2 (insulin like growth factor binding protein 2)
- IGFBP-3
- IGFBP-4
- IgG
- IgG1
- IgG2
- IgG3
- IgG4
- IgM
- IL1
- IL10
- IL11
- IL12
- IL12a (IL12p35)
- IL12b (IL23p40)
- IL12p70
- IL13
- IL15
- IL16
- IL17
- IL17a
- IL17af
- IL17B
- IL17C
- IL17F
- IL18
- IL18 BPa
- IL18BP (Interleukin-18 Binding Protein)
- IL19
- IL1a
- IL1b
- IL1RA [Interleukin-1 Receptor Antagonist]
- IL1RAcP
- IL1RL1 [Interleukin 1 Receptor Like 1]
- IL2
- IL20
- IL21
- IL22
- IL22BP
- IL23 (p19/p40)
- IL23p19 (IL23a)
- IL24
- IL25
- IL26
- IL27
- IL28a
- IL29
- IL2R
- IL2Ra (sCD25)
- IL3
- IL31
- IL32
- IL33
- IL34
- IL35
- IL36
- IL36a
- Il36g
- IL36R
- IL37
- IL38
- IL4
- IL4 soluble receptor alpha (IL-4sRa)
- IL-41 (Meteorin-like protein)
- IL5
- IL5 Ralpha
- IL6
- IL7
- IL8
- IL9
- Immune complexes (IC)
- Immunoreactive LTC4 (iLTC4)
- INFa2 [Interferon alpha 2]
- Insulin
- Interferon (IFN)
- Iron
- ischemia-modified albumin (IMA)
- Kallikrein 8
- Keratinocyte growth factor
- KL-6
- Kynurenine
- Lactate
- Lactate dehydrogenase
- Laminin (LN)
- LDL-cholesterol
- Leptin
- L-FABP
- LIF (leukemia inhibitory factor)
- LIGHT (TNFSF14, CD258)
- Linoleic Acid
- Lipase
- Lipocalin-2
- Lp(a) (lipoprotein A)
- LRG (leucine-rich alpha-2 glycoprotein)
- LTB4
- LTC4
- LTD4
- LTE4
- Luteinizing hormone (LH)
- Lysozyme
- MAO [Monoamine Oxidase]
- Mast cell chymase
- Mast cell tryptase
- MCP (CD46)
- MCSF
- MDA (malondialdehyde)
- Melatonin
- MIF
- MMP1
- MMP10
- MMP12
- MMP13
- MMP2
- MMP3
- MMP7
- MMP8
- MMP9
- M-protein (Myeloma protein)
- MSPa (macrophage stimulating protein a)
- MUFA (Monounsaturated Fatty Acids)
- Myeloperoxidase (MPO)
- Myoglobin
- Neopterin
- Neurofilament light chain
- Neuron-specifc enolase (NSE)
- Neuropeptide Y
- Neurotrophin-3 (NT-3)
- Neurotrophin-4 (NT-4)
- Neutrophil elastase
- NF-kB
- NGF [Nerve Growth Factor]
- NGF-beta (beta-nerve growth factor)
- NLRP3 (Nod-like receptor protein 3 inflammasome)
- NO [Nitric Oxide]
- Nonesterified Fatty Acid (NEFA)
- Non-HDL-unesterified cholesterol
- Notch-3
- NT-proBNP (N-terminal brain natriuretic peptide)
- Oleic Acid
- Omentin
- Oncostatin-M
- ONOO (Peroxynitrite)
- Orosomucoid
- Osteocalcin
- Osteopontin (OPN)
- Osteoprotegerin (OPG)
- Parathormone (PTH)
- PARC (recombinant human MIP-4)
- PC-III (type III pre-collagen)
- PDGF
- PDGF-AB/BB
- PDGF-BB [Platelet Derived Growth Factor-BB]
- PDGF-АА
- Pentraxin-3
- Perforin
- Periostin
- Peroxiredoxin 4 (Prx4)
- PGE1
- PGE2 [Prostaglandin E2]
- Phosphatidylcholine
- PIIINP (procollagen-III N-terminal peptide)
- PINP (amino-terminal propeptide of procollagen type I)
- PIVKA-II
- Plasmin-alpha2-plasmin inhibitor complex (PIC)
- Plasminogen
- Plasminogen activator inhibitor-1 (PAI-1)
- Platelet Endothelial Cell Adhesion Molecule 1 (PECAM-1)
- Platelet-Activating Factor (PAF)
- Pleiotrophin (PTN)
- PlGF-1 (Placental growth Factor 1)
- Prealbumin
- Presepsin
- pro-BNP (pro-B-type natriuretic peptide)
- Procalcitonin
- Procollagen-3
- Progastrin‐releasing peptide (ProGRP)
- Prolactin (PRL)
- Prostaglandin D2
- Prostaglandin F2b (PGF2b)
- Prostaglandin F2α (PGF2α)
- Protein carbonyls
- Protein total
- Proteinase 3
- PSA (prostate‐specific antigen)
- P-tau (phosphorylated tau)
- PUFA (Polyunsaturated Fatty Acids)
- RANKL (TNFSF11)
- Resistin
- Retinol-binding protein (RBP)
- Retinol-binding protein 4 (RBP-4)
- RF (Rheumatoid Factor)
- RF-IgM
- RIPK1 (receptor-interacting protein kinase-1)
- S100A8/A9
- sAbetaPPbeta
- sC5b-9
- sCD14
- sCD163
- sCD23
- sCD27
- sCD30
- sCD4
- sCD40L
- sCD8
- sCD86
- SCGF-b (Stem Cell Growth Factor beta)
- sc-kit (SCFR)
- Secretory Leukocyte Protease Inhibitor (SLPI)
- sEGFR (Soluble epidermal growth factor receptor)
- Selenium
- Serum amyloid A
- sE-selectin
- SFA (Saturated Fatty Acids)
- sFasL
- sFRP-3
- Sgp130 (Soluble Glycoprotein 130)
- Siglec-5
- sIL-18Ra
- sIL1R1 (Soluble Interleukin-1 Receptor-1)
- sIL1R2 (Soluble Interleukin-1 Receptor-2)
- sIL1R3 (Soluble Interleukin-1 Receptor-3)
- sIL1R4 (Soluble Interleukin-1 Receptor-4)
- sIL2R
- sIL2Ra (Soluble Interleukin-2 Receptor subunit alpha)
- sIL6R
- sIL6Ra
- sIL7R
- sILT3
- sLAG-3
- SLAMF8
- sLLT1
- sL-selectin
- Soluble transferrin receptor (sTfR)
- soluble triggering receptor expressed on myeloid cells 1 (sTREM-1)
- SP-40,40 (clusterin)
- sPD-1
- sPD-L1
- Sphingomyelin
- sP-selectin
- Squamous cell carcinoma antigen (SCC)
- sST2 (Soluble suppression of tumorigenicity-2)
- Stem Cell Factor (SCF)
- sTIE-2 (soluble angiopoietin receptor 2)
- sTNF-R1
- sTNF-R2
- sTREM2 (soluble triggering receptor expressed on myeloid cells 2)
- Substance P (SP)
- SuperOxide Dismutase (SOD)
- Surfactant protein A (SP-A)
- Surfactant protein D (SP-D)
- sVEGFR1
- sVEGFR2
- Taurine
- TgAb (thyroglobulin antibodies)
- TGFa
- TGFb
- TGFb1
- TGFb1R1
- TGFb1R2
- TGFb2
- TGFb3
- Thioredoxin 1 (TRX1)
- Thrombin-antithrombin complex (TAT)
- Thrombopoietin (TPO, MGDF)
- Thrombospondin-2 (THBS2)
- Thromboxane B2 (TXB2)
- Thyroglobulin (TG)
- Tim-3 (HAVCR2)
- TIMP1
- TIMP2
- Tissue factor
- Tissue Plasminogen Activator (tPA)
- Tissue plasminogen activator (tPA)/plasminogen activator inhibitor type I (PAI) complex (tPA/PAI)
- TL1A (TNFSF15)
- TNFa
- TNFb
- TNFR1
- TNFRSF19L
- TNTHSST (high-sensitivity troponin T)
- Total bile acid (TBA)
- Total cholesterol
- Total testosterone
- TPOAb (Thyroid peroxidase antibody)
- TRAb (thyrotropin receptor autoantibody)
- TRAIL (TNF-related apoptosis-inducing ligand)
- TRAIL R1
- Transferrin
- Triglyceride
- Triglycerides
- Troponin
- Troponin I
- Troponin T
- Tryptase
- TSH (thyroid-stimulating hormone)
- TSLP
- T-tau (total tau)
- TWEAK
- Unesterified cholesterol
- Urate
- Urokinase-type plasminogen activator (uPA)
- VAP-1 (vascular adhesion protein-1)
- VCAM-1 (vascular cell adhesion molecule-1)
- VEGF [Vascular Endothelial Growth Factor]
- VEGF-A
- VEGF-C
- VEGF-D
- VIP [Vasoactive Intestinal Peptide]
- Visfatin
- Vitamin A
- Vitamin B12
- Vitamin B6
- VLDL
- XCL1
- α-hydroxybutyrate dehydrogenase (α-HBDH)
- α-L-fucosidase
-
-
- 5HT1AR+
- 5HT2AR+
- AA1+
- a-GalCer/CD1d tetramer+
- ALDH+
- alpha/beta-TCR+
- Annexin V+
- arginase-1+
- B7-Н3+
- bcl2+
- Bcl6+
- BDCA1+
- BDCA2+
- BDCA3+
- BDCA4+
- BDNF+
- BLIMP-1low
- BR3+
- BTLA+
- C3 receptor (CRL)+
- C38++
- CCL1+ (I-309+)
- CCL17+ (TARC+)
- CCL22+ (MDC+)
- CCR1+
- CCR10-
- CCR10+
- CCR2+ (CD192+)
- CCR3+
- CCR4-(CD194-)
- CCR4-/+(CD194-/+)
- CCR4+(CD194+)
- CCR4neg
- CCR5-(CD195-)
- CCR5+(CD195+)
- CCR6-(CD196-)
- CCR6-/+(CD196-/+)
- CCR6+(CD196+)
- CCR6neg
- CCR7(CD197)-
- CCR7+ (CD197)
- CCR8+
- CCR9+
- CD1+
- CD10-
- CD10+
- CD101+
- CD103-
- CD103+
- CD105-
- CD105+
- CD106-
- CD106+
- CD107+
- CD107a+ (LAMP-1)
- CD112+
- CD117+
- CD11b-
- CD11b+
- CD11c-
- CD11c_hi
- CD11c_int
- CD11c_low
- CD11c+
- CD12+
- CD122 (IL2Rb)+
- CD123+
- CD123dim
- CD123high
- CD123inter
- CD123low
- CD124 (IL4RA)+
- CD126 (IL6Ra)+
- CD127-
- CD127-/dim
- CD127+
- CD127low
- CD127low/-
- CD132 (IL2RG)+
- CD133-
- CD133+
- CD134+ (OX40+)
- CD137+ (4-1BB)
- CD138-/+
- CD138+
- CD14-
- CD14 Bright
- CD14-/low
- CD14+
- CD14++
- CD141-(BDCA3-)
- CD141+ (BDCA3+)
- CD144+
- CD146-
- CD146(MCAM)+
- CD14dim
- CD14hi
- CD14low
- CD15-
- CD15+
- CD152+
- CD154+
- CD155+
- CD158a+
- CD158b+
- CD158b1+ (p58.2+)
- CD158e+ (p70+)
- CD158h+
- CD158j+
- CD158k+ (p140+)
- CD15high
- CD16-
- CD16+
- CD16++
- CD161-
- CD161+
- CD161bright
- CD161hi
- CD162+ (PSGL1)
- CD163-
- CD163+
- CD163dim
- CD163high
- CD163low
- CD169-
- CD169+
- CD169high
- CD169low
- CD16b- (FcgRIIIb-)
- CD16bright
- CD16dim
- CD16high
- CD16neg
- CD16neg/dim
- CD16pos
- CD18+
- CD183-
- CD183+ (CXCR3)
- CD19-
- CD19+
- CD196-
- CD196+
- CD19low
- CD1a-
- CD1a_hi
- CD1a_int
- CD1a+
- CD1b/c+
- CD1b+
- CD1c-
- CD1c+ (BDCA1+)
- CD1d high
- CD1d+
- CD2+
- CD20-
- CD20+
- CD205+
- CD206+
- CD206+ (MMR+)
- CD206+/high
- CD206+/low
- CD209+(DC-SIGN)
- CD20low
- CD21-
- CD21+
- CD212+ (IL-12R-b2)
- CD21low
- CD21neg/lo
- CD226-
- CD226+
- CD23-
- CD23+
- CD24-
- CD24 low
- CD24+
- CD24++
- CD243-
- CD243+
- CD244(2B4,SLAMF4)+
- CD24high
- CD24int
- CD25- (IL-2Rα-)
- CD25-/+ (IL-2Rα-/+)
- CD25+ (IL-2Rα+)
- CD25+/high (IL-2Rα+/high)
- CD25++ (IL-2Rα++)
- CD25+++ (IL-2Rα+++)
- CD25bright (IL-2Rα bright)
- CD25high (IL-2Rα high)
- CD25int
- CD25low
- CD25low/- (IL-2Rα low/-)
- CD25med
- CD25neg
- CD26-
- CD26+
- CD267+ (TNFRSF13B+, TACI+)
- CD268+ (BAFF-R+, TNFRSF13C+)
- CD269+ (BCMA+, TNFRSF13B+, TNFRSF17+)
- CD26high
- CD27-
- CD27+
- CD27+/-
- CD27++
- CD274+
- CD279+
- CD27BR
- CD27hi
- CD28-
- CD28+
- CD28+/-
- CD282+ (TLR2+)
- CD284+ (TLR4+)
- CD29(integrin beta1)+
- CD29(integrin beta1)high
- CD3-
- CD3+
- CD30(TNFRSF8)+
- CD303- (BDCA2-)
- CD303+ (BDCA2+)
- CD304- (BDCA4-,Nrp1-)
- CD304+ (BDCA4+,Nrp1+)
- CD31+
- CD314(NKG2D)-
- CD314(NKG2D)+
- CD319(SLAMF7)+
- CD32-
- CD33+
- CD33hi
- CD33inter
- CD33neg/dim
- CD34+
- CD352(NTBA,SLAMF6)+
- CD36+
- CD38-
- CD38-/+
- CD38-/lo
- CD38+
- CD38+/-
- CD38++
- CD38BR
- CD38high
- CD38int
- CD38low
- CD38low/-
- CD38neg
- CD39+
- CD3e-
- CD3e+
- CD4-
- CD4+
- CD4+/-
- CD40+
- CD43+
- CD44+
- CD45-
- CD45-/dim
- CD45+
- CD45bright
- CD45dim
- CD45R-
- CD45R+
- CD45RA-
- CD45RA high
- CD45RA low
- CD45RA+
- CD45RA+/-
- CD45RAbright
- CD45RAneg
- CD45RBhigh
- CD45RBlow
- CD45RO-
- CD45RO+
- CD45RO++
- CD45ROhigh
- CD45ROlow
- CD45ROMed
- CD48+
- CD49a+
- CD49d-
- CD49d high (VLA4 high)
- CD4dim
- CD4hi
- CD4lo
- CD5-
- CD5+
- CD5+/-
- CD54+
- CD55+
- CD56-
- CD56+
- CD56bright
- CD56dim
- CD56hi
- CD56int
- CD56low
- CD57+
- CD62L-
- CD62L+ (L-selectin)
- CD62L+/- (L-selectin)
- CD62Llow
- CD63+
- CD64(FcgRI)+
- CD66+
- CD66b- (CEACAM8-)
- CD66b+
- CD68-
- CD68+
- CD69+
- CD7-
- CD7+
- CD70+
- CD71+
- CD73-
- CD73+
- CD74
- CD77-
- CD77+
- CD78+
- CD79+
- CD8-
- CD8+
- CD80+
- CD83-
- CD83+
- CD85j+
- CD86+
- CD8bright
- CD8hi
- CD8lo
- CD94+
- CD95-
- CD95(FasR)+
- CD95+/-
- CD95high
- CD95Low/Med
- CD95Med
- CD96+
- CFSE-
- CK-
- CK+
- CLA-
- CLA+
- CRTH2+
- CTLA-4-
- CTLA-4_Intracellular+
- CTLA-4_Surface+
- CTLA-4+
- CX3CR1+
- CXCL13+
- CXCL8+(IL8+)
- CXCR1+
- CXCR2+
- CXCR3-(CD183-)
- CXCR3-/+(CD183-/+)
- CXCR3+(CD183+)
- CXCR3hi(CD183hi)
- CXCR3neg
- CXCR4+
- CXCR5-(CD185-)
- CXCR5+(CD185+)
- CXCR5hi/int(CD185hi/int)
- CXCR6(CD186)-
- CXCR7+
- DC-LAMP+
- DR+
- DR3+
- EB6+
- E-cadherin+
- ECP+
- EG1+
- EG2+
- Elastase+
- Eomes_hi
- eotaxin+
- Epcam+
- EZH2-
- EZH2+
- Fas-
- FasL (CD95L/CD178)
- FceRI+
- FceRII+
- FcRL4+
- FcRL5+
- fHOBIThigh
- FOXP3-
- FOXP3+
- FoxP3dim
- FoxP3high
- FoxP3Int
- FoxP3low
- FSC_high
- FSC_low
- gamma/delta-TCR-
- gamma-delta-TCR+
- gammaTCS1+
- gammaV1+
- gammaV2+
- GARP+
- Gata-3+
- GITR+
- gl183+
- GM-CSF+
- GM-CSFR+
- GranzymeA-
- GranzymeA+
- GranzymeB-
- GranzymeB+
- GranzymeK+
- GranzymeM+
- GZMB+
- HBcAg-specific+
- HBsAg-specific+
- Helios+
- HLA-ABC+
- HLA-DR-
- HLA-DR-/low
- HLA-DR+
- HLA-DR+/-
- HLA-DRdim
- HLA-DRhigh
- HLA-DRint
- HLA-DRlow
- HMGB1-
- HNK-1+
- ICOS+
- ICOShigh
- ICOSL+
- ICOSLhi
- IDO+
- IFNa+
- IFNb+
- IFNg-
- IFNg+
- IgA+
- IgD-
- IgD high
- IgD low
- IgD+
- IgD++
- IgE+
- IgG-
- IgG+
- IgG4+
- IgM-
- IgM high
- IgM low/int
- IgM+
- IgM+/-
- IL10-
- IL10+
- IL10R+
- IL10Ra+
- IL10Rb+
- IL11+
- IL11Ra+
- IL12+
- IL12p70+
- IL13+
- IL15+
- IL15Ra(CD215)+
- IL17-
- IL17+
- IL17a-
- IL17a+
- IL17F+
- IL17RC
- IL18+
- IL18R+
- IL18Ra+
- IL1R1+
- IL2-
- IL2+
- IL20R1+
- IL21+
- IL21R
- IL22-
- IL22+
- IL22R+
- IL23p19+
- IL23R+
- IL25+
- IL2R+
- IL33+
- IL35+
- IL36R+
- IL37+
- IL4-
- IL4+
- IL5+
- IL6+
- IL6R+
- IL7Ra high
- IL7Ra low
- IL7Ra+
- IL9+
- ILT3high
- iNOS+
- Integrin alpha4 beta7 (LPAM-1)-
- Integrin alpha4 beta7 (LPAM-1)+
- Integrin beta7+
- IP-10(CXCL10)+
- I-TAC(CXCL11)+
- Ki67-
- Ki67+
- KLRG1+
- LAG3-
- LAG3+
- Langerin+ (CD207+)
- LAP+
- Lin-
- Lin- (CD3-, CD19-, CD56-)
- Lin1-
- Lin1low/-
- LLT1+
- MAC387+
- Mast Cell Chimase+ (MCC+)
- Mast Cells Tryptase+ (MCT+)
- MBP+
- Melan-A tetramer+
- MHC-I+
- MHCII+ (HLAII+)
- MPO+ (myeloperoxidase+)
- MRP8-
- MRP8+
- MUM+
- MUM1+
- Neutrophil elastase+
- NGF+
- NKB1+
- NKG2A
- NKG2C+(KLRC2,CD159c)
- NKp30
- NKp44
- NKp46
- normal ratio kappa/lambda
- NT3+
- NY-ISO-1
- OX40+
- OX40L+
- p53+
- p75+ (AIRM-1+)
- PAX
- PCA-1
- PD-1(CD279)-
- PD-1+
- PD-1++(high)
- PD-L1-
- PD-L1+(B7-H1+)
- PD-L1hi
- PD-L1int
- PD-L1low
- Perforin-
- Perforin+
- PRF1+
- pSTAT3+
- restriction kappa/lambda
- RORc+
- RORgt+
- RUNX3+
- S-AF647+
- S-BV421+
- SERT+
- SIRPa+(CD172A+)
- SLAMF1(CD150)+
- SLAMF3(CD229+)
- SLAMF5(CD84)+
- SSC_high
- SSC_low
- SSC_med
- T-bet_dim
- T-bet_hi
- T-bet_int
- T-bet_lo
- T-bet+
- TCF1+
- TCR-zeta bright
- TCR-zeta dim
- TCR-zeta int
- TGFb-
- TGFb+
- TIGIT-
- TIGIT+
- TIM-3+
- Tissue Factor+ (TF+)
- TLR3+
- TLR4+
- TLR7+
- TLR9+
- TNFa-
- TNFa hi
- TNFa low
- TNFa+
- TNFR2(TNFRSF1B)+
- TOX+
- TR+(Transferrin receptor)
- TRAIL+
- Tryptase+
- TSLP+
- UCHL1+
- Va12+
- Va2+
- Va24+
- Va24-Ja18(6B11)+
- Va7.2+
- vb1+
- Vb11+
- Vb12+
- vb13.1+
- vb13.2+
- vb13.6+
- Vb13+
- vb14+
- vb16+
- vb17+
- vb18+
- Vb2+
- vb20+
- vb21.3+
- vb21+
- vb22+
- vb23+
- Vb3+
- Vb4+
- vb5.1+
- Vb5.2+
- Vb5.3+
- Vb6.1+
- vb7.1+
- vb7.2+
- Vb8+
- Vb9+
- Vd1+
- Vd2-
- Vd2+
- VEGFR2+
- Vg9+
- VLA1+(integrin-a1b1)
- ZAP-70 bright
- ZAP-70 dim
- ZAP-70 int
- 71549 values of cytokine/cell concentrations;
- data extracted from 1882 papers/other public sources.